Journal
Contemporary Clinical Trials Communications
Publication Date
6-1-2021
Volume
22
First Page
100798
Document Type
Open Access Publication
DOI
10.1016/j.conctc.2021.100798
Rights and Permissions
Srinivasan M, Bacharier LB, Goss CW, Zhou Y, Boomer J, Bram S, Burgdorf D, Burnham CA, Casper T, Castro M, Coverstone A, Haslam M, Kanchongkittiphon W, Kuklinski C, Lian Q, Schechtman K, Storch GA, True K, Wallace MA, Yin-DeClue H, Ahrens E, Wang J, Beigelman A. The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population. Contemp Clin Trials Commun. 2021 Jun 9;22:100798. doi: 10.1016/j.conctc.2021.100798 © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Srinivasan, Mythili; Bacharier, Leonard B; Goss, Charles W; Zhou, Yanjiao; Boomer, Jonathan; Bram, Sarah; Burgdorf, Dana; Burnham, Carey-Ann; Casper, Timothy; Castro, Mario; Coverstone, Andrea; Haslam, Matthew; Kanchongkittiphon, Watcharoot; Kuklinski, Cadence; Lian, Qinghua; Schechtman, Kenneth; Storch, Gregory A; true, Kelly; Wallace, Meghan A; Yin-DeClue, Huiqing; Ahrens, Elizabeth; Wang, Jinli; and Beigelman, Avraham, "The Azithromycin to Prevent Wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population." Contemporary Clinical Trials Communications. 22, 100798 (2021).
https://digitalcommons.wustl.edu/oa_4/617
